# COL7A1

## Overview
The COL7A1 gene encodes the collagen type VII alpha 1 chain, a crucial structural protein categorized as a collagenous component of the extracellular matrix. This protein is primarily responsible for forming anchoring fibrils that secure the dermal-epidermal junction, thereby maintaining skin integrity and resilience. The collagen type VII alpha 1 chain is synthesized as a homotrimer, forming a triple helix that undergoes post-translational modifications to achieve its mature form. These anchoring fibrils interact with various extracellular matrix components, such as laminin-332 and integrins, playing a vital role in skin adhesion and wound healing processes (Nyström2013Collagen; Chung2010Type). Mutations in the COL7A1 gene are linked to dystrophic epidermolysis bullosa, a genetic disorder characterized by skin fragility and blistering, highlighting the gene's clinical significance (Bremer2019Natural).

## Structure
The COL7A1 gene encodes type VII collagen, a key component of anchoring fibrils in the skin. The protein is composed of a long triple-helical domain flanked by non-collagenous NC-1 and NC-2 domains. The primary structure includes a central collagenous domain characterized by Gly-X-Y repeats, interrupted by 19 imperfections, which provide flexibility (Christiano1994Cloning; Sakuntabhai1998Deletions). The NC-1 domain is approximately 145 kDa and contains submodules with homology to adhesive proteins, such as fibronectin type III-like domains and a segment homologous to the von Willebrand factor A domain (Christiano1994Cloning; Chung2010Type). The NC-2 domain is smaller, around 30 kDa, and contains a segment homologous to the Kunitz protease inhibitor (Chung2010Type).

The tertiary structure involves the formation of a triple helix, stabilized by intermolecular disulfide bonds (Christiano1994Cloning). Quaternary structure is characterized by the assembly of these helices into anchoring fibrils, which are crucial for dermal-epidermal adhesion (Chung2010Type). Post-translational modifications include hydroxylation of proline and lysine residues, and O-glycosylation of hydroxylysine residues (Christiano1994Cloning). These structural features are essential for the protein's function in maintaining skin integrity.

## Function
The COL7A1 gene encodes collagen type VII, a crucial component of anchoring fibrils in the skin. These fibrils are essential for maintaining the structural integrity of the dermal-epidermal junction, where the epidermis connects to the dermis (Järvikallio1997Molecular). In healthy human cells, collagen VII is primarily synthesized by keratinocytes and, to a lesser extent, by fibroblasts (Sat2000Tissuespecific; Nagy2011HBEGF). The protein forms a homotrimer of three α1(VII) chains, which assemble into a triple helix structure. This structure is stabilized by interchain disulfide bonds and undergoes further processing to form mature collagen VII, which polymerizes into anchoring fibrils (Fritsch2009Dominantnegative; Järvikallio1997Molecular).

Collagen VII is primarily active in the extracellular matrix, where it plays a vital role in anchoring the epidermis to the dermis, providing mechanical strength and resilience to the skin (Sat2000Tissuespecific). This structural arrangement is crucial for preventing blistering and maintaining the skin's resilience against mechanical stress (Järvikallio1997Molecular). The stability and slow turnover of collagen VII make it advantageous for long-term skin integrity, as even partial expression can maintain epidermal-dermal adhesion (Sat2000Tissuespecific).

## Clinical Significance
Mutations in the COL7A1 gene are primarily associated with dystrophic epidermolysis bullosa (DEB), a genetic disorder characterized by skin fragility and blistering. DEB can be inherited in both autosomal dominant (DDEB) and recessive (RDEB) forms, with varying severity. The severity of DEB is generally correlated with the quantity and functionality of type VII collagen expressed (Bremer2019Natural). 

In DDEB, glycine substitutions in the triple helical domain of collagen VII, particularly in exon 73, can impair stable triple helix formation, leading to skin blistering (HammamiHauasli1998Some; Bremer2019Natural). In RDEB, bi-allelic null variants often cause severe generalized blistering and scarring, with complications such as aggressive squamous cell carcinomas (Bremer2019Natural). Milder RDEB phenotypes result from at least one allele capable of producing imperfect pro-α1 type VII collagen (Bremer2019Natural).

Mutations in the COL7A1 gene can also affect splicing signals, leading to exon skipping, which is a potential target for antisense oligonucleotide-mediated exon skipping therapy (Bremer2019Natural). The gene's mutations are distributed throughout its 118 exons, with over 700 reported variants (Bremer2019Natural).

## Interactions
The COL7A1 gene encodes type VII collagen, which plays a crucial role in dermal-epidermal adhesion by forming anchoring fibrils. These fibrils interact with several extracellular matrix components, including laminin-332, collagen types I and IV, and fibronectin. The NC1 domain of type VII collagen specifically binds to these components, facilitating the attachment of the basement membrane to the dermis (Chen1997Interactions).

Type VII collagen interacts with laminin-332 and integrin α6β4 at the dermal-epidermal junction, which is essential for proper skin integrity and wound healing. This interaction is critical for organizing laminin-332 and influencing the expression and distribution of integrin α6β4, which guides keratinocyte migration during wound healing (Nyström2013Collagen).

In addition to its structural role, type VII collagen influences cell signaling pathways. The absence of COL7A1 disrupts the laminin-332/integrin α6β4 signaling axis, affecting downstream components like JNK and STAT3, which are involved in cell migration and wound healing processes (Nyström2013Collagen). These interactions highlight the multifaceted role of type VII collagen in maintaining skin structure and function.


## References


[1. (Sat2000Tissuespecific) E Sat, K H Leung, L Bruckner-Tuderman, and K S E Cheah. Tissue-specific expression and long-term deposition of human collagen vii in the skin of transgenic mice: implications for gene therapy. Gene Therapy, 7(19):1631–1639, October 2000. URL: http://dx.doi.org/10.1038/sj.gt.3301281, doi:10.1038/sj.gt.3301281. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/sj.gt.3301281)

[2. (Nyström2013Collagen) Alexander Nyström, Daniela Velati, Venugopal R. Mittapalli, Anja Fritsch, Johannes S. Kern, and Leena Bruckner-Tuderman. Collagen vii plays a dual role in wound healing. Journal of Clinical Investigation, 123(8):3498–3509, July 2013. URL: http://dx.doi.org/10.1172/jci68127, doi:10.1172/jci68127. This article has 173 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci68127)

[3. (Chen1997Interactions) Mei Chen, M. Peter Marinkovich, Arthur Veis, Xiaoyan Cai, Chilukuri N. Rao, Edel A. O’Toole, and David T. Woodley. Interactions of the amino-terminal noncollagenous (nc1) domain of type vii collagen with extracellular matrix components. Journal of Biological Chemistry, 272(23):14516–14522, June 1997. URL: http://dx.doi.org/10.1074/jbc.272.23.14516, doi:10.1074/jbc.272.23.14516. This article has 151 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.272.23.14516)

[4. (Fritsch2009Dominantnegative) Anja Fritsch, Sashko Spassov, Susanne Elfert, Andreas Schlosser, Yannick Gache, Guerrino Meneguzzi, and Leena Bruckner-Tuderman. Dominant-negative effects of col7a1 mutations can be rescued by controlled overexpression of normal collagen vii. Journal of Biological Chemistry, 284(44):30248–30256, October 2009. URL: http://dx.doi.org/10.1074/jbc.M109.045294, doi:10.1074/jbc.m109.045294. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M109.045294)

[5. (Chung2010Type) Hye Jin Chung and Jouni Uitto. Type vii collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. Dermatologic Clinics, 28(1):93–105, January 2010. URL: http://dx.doi.org/10.1016/j.det.2009.10.011, doi:10.1016/j.det.2009.10.011. This article has 222 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.det.2009.10.011)

[6. (HammamiHauasli1998Some) Nadja Hammami-Hauasli, Hauke Schumann, Michael Raghunath, Oliver Kilgus, Ursula Lüthi, Thomas Luger, and Leena Bruckner-Tuderman. Some, but not all, glycine substitution mutations incol7a1 result in intracellular accumulation of collagen vii, loss of anchoring fibrils, and skin blistering. Journal of Biological Chemistry, 273(30):19228–19234, July 1998. URL: http://dx.doi.org/10.1074/jbc.273.30.19228, doi:10.1074/jbc.273.30.19228. This article has 66 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.273.30.19228)

[7. (Bremer2019Natural) Jeroen Bremer, Elisabeth H. van der Heijden, Daryll S. Eichhorn, Rowdy Meijer, Henny H. Lemmink, Hans Scheffer, Richard J. Sinke, Marcel F. Jonkman, Anna M.G. Pasmooij, and Peter C. Van den Akker. Natural exon skipping sets the stage for exon skipping as therapy for dystrophic epidermolysis bullosa. Molecular Therapy - Nucleic Acids, 18:465–475, December 2019. URL: http://dx.doi.org/10.1016/j.omtn.2019.09.009, doi:10.1016/j.omtn.2019.09.009. This article has 29 citations.](https://doi.org/10.1016/j.omtn.2019.09.009)

[8. (Christiano1994Cloning) A.M. Christiano, D.S. Greenspan, S. Lee, and J. Uitto. Cloning of human type vii collagen. complete primary sequence of the alpha 1(vii) chain and identification of intragenic polymorphisms. Journal of Biological Chemistry, 269(32):20256–20262, August 1994. URL: http://dx.doi.org/10.1016/s0021-9258(17)31984-1, doi:10.1016/s0021-9258(17)31984-1. This article has 164 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)31984-1)

[9. (Sakuntabhai1998Deletions) Anavaj Sakuntabhai, Nadja Hammami-Hauasli, Christine Bodemer, Ariane Rochat, Catherine Prost, Yann Barrandon, Yves de Prost, Mark Lathrop, Fenella Wojnarowska, Leena Bruckner-Tuderman, and Alain Hovnanian. Deletions within col7a1 exons distant from consensus splice sites alter splicing and produce shortened polypeptides in dominant dystrophic epidermolysis bullosa. The American Journal of Human Genetics, 63(3):737–748, September 1998. URL: http://dx.doi.org/10.1086/302029, doi:10.1086/302029. This article has 36 citations.](https://doi.org/10.1086/302029)

[10. (Järvikallio1997Molecular) Anitta Järvikallio, Leena Pulkkinen, and Jouni Uitto. Molecular basis of dystrophic epidermolysis bullosa: mutations in the type vii collagen gene (col7a1). Human Mutation, 10(5):338–347, 1997. URL: http://dx.doi.org/10.1002/(SICI)1098-1004(1997)10:5<338::AID-HUMU2>3.0.CO;2-B, doi:10.1002/(sici)1098-1004(1997)10:5<338::aid-humu2>3.0.co;2-b. This article has 126 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/(SICI)1098-1004(1997)10:5)

[11. (Nagy2011HBEGF) Nikoletta Nagy, Noor Almaani, Akio Tanaka, Joey E. Lai-Cheong, Tanasit Techanukul, Jemima E. Mellerio, and John A. McGrath. Hb-egf induces col7a1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis bullosa. Journal of Investigative Dermatology, 131(8):1771–1774, August 2011. URL: http://dx.doi.org/10.1038/jid.2011.85, doi:10.1038/jid.2011.85. This article has 57 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/jid.2011.85)